About this book
- Contains the science and clinical information needed to help make decisions about the applications of brain PET to the care of patients with symptoms of Alzheimer's disease and related disorders
- Dr. Dan Silverman and his contributors cover functional imaging, goals and limitations, clinical interpretation, and evaluation
- Enhanced with PET scans and clinical cases, this book fills a growing need
The high demand for brain PET scans in dementia and related disorders is driven by both the prevalence of these conditions and the difficulty of distinguishing the causes of cognitive impairment. The clinical utility of brain PET in such cases depends in part on how accurately and fully the information inherently represented in a scan is appreciated and relayed in the interpretation of the images. Since this can be challenging for even the most highly trained imaging specialists, PET in the Evaluation of Alzheimer's Disease and Related Disorders takes a ground-up look at PET as it relates to the evaluation of patients with cognitive impairment. Expert contributors weigh in on when and why to order brain PET scans, their clinical interpretation, FDG PET in the evaluation of mild cognitive impairment and early dementia, PET and SPECT for central motor disorders, microstructural imaging of neurodegenerative changes, and amyloid imaging. The book is illustrated throughout with color images and also includes an interpretive practice atlas for self-testing of skills.
Written for: Radiologists, neuroradiologists, and nuclear physicians, neurologists, residents
Table of contents
Part 1: Imaging applications in current clinical practice.- Clinical evaluation of dementia and when to get pet.- Clinical interpretation of brain pet scans: Performing visual assessments, providing quantifying data, and generating integrated reports.- Fdg pet in the evaluation of mild cognitive impairment and early dementia.- Pet and spect in the evaluation of patients with central motor disorders.- Part 2: Emerging approaches using pet.- Microstructural imaging of neurodegenerative changes.- Amyloid imaging with pet in Alzheimer's disease, mild cognitive impairment and clinical unimpaired subjects.- Part 3: Atlas.- Interpretive practice atlas.